Emiconductor And Artificial Intelligence Deep Tech Customized Financial Investment Services Diverse Real Estate Holdings Augment Equity Assets Support Portfolio Companies As They Grow Bridgewest Group Is Based In The Us News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MIAMI and PERTH, Australia, April 26, 2023 /PRNewswire/ Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, establishes LumaCina business unit under Bridgewest Perth Pharma in Perth, Australia. The newly created business leverages the acclaimed team and production facility recently acquired by Bridgewest Group from Pfizer (Perth) Pty Ltd, a subsidiary of Pfizer, Inc., plus the addition of newly expanded capabilities, most notably, R & D. LumaCina will commercialize sterile injectable drugs in global markets and is actively expanding its portfolio through increased production under LumaCina branding. "Our recent acquisitions in Australia are a reflection of the importance we place in meeting the growing demand for high quality pharmaceuticals, both regionally, and globally. LumaCina increases our ability to help healthcare professionals readily access quality sterile injectable medicines w ....

Western Australia , New Zealand , United States , Jenny Bourbiel , Jon Kafer , Masood Tayebi , Ian Wisenberg , Life Sciences , Perth Pharma Pty Ltd , Pfizer Inc , Bridgewest Group Portfolio Company , Bridgewest Group , Pfizer Perth Pty Ltd , Bridgewest Perth Pharma , Pty Ltd , Chief Commercial Officer , Bridgewest Perth Pharma Pty Ltd , Pfizer Perth , Chief Executive Officer , Bridgewest Group Portfolio , Media Contact , Miami And Perth , April 26 , 023 Prnewswire Global Private Investment Firm , Bridgewest Group , Ecognized For Developing Innovative Companies In Life Sciences ,